The role of adrenergic signaling in breast cancer biology

Cancer Biomarkers

Volumn 13, Issue 3, 2013, Pages 161-169

  Obeid, Elias I ^a   Conzen, Suzanne D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

adrenergic signaling; Breast cancer; glucocorticoids; HPA axis; stress

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; COLONY STIMULATING FACTOR 1; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; METYRAPONE; NORADRENALIN; PROPRANOLOL; TRICYCLIC ANTIDEPRESSANT AGENT; VASCULOTROPIN;

ADJUVANT CHEMOTHERAPY; ADRENERGIC ACTIVITY; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANGIOGENESIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BREAST; BREAST CANCER; CANCER CELL; CANCER INCIDENCE; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; DISEASE FREE SURVIVAL; DRUG EXPOSURE; EARLY CANCER; HIGH RISK PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACELLULAR SIGNALING; METASTASIS POTENTIAL; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; SOCIAL STRESS; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ADRENERGIC BETA-ANTAGONISTS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84881420094     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130347     Document Type: Article

References (61)

1. Sapolsky R.Why Zebras Don't Get Ulcers (1994, Holt Paperbacks/ Owl 3rd Rep. Ed. 2004) ISBN 0-8050-7369-8.
2. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nature reviews. Immunology. Mar 2005; 5(3): 243-251. (Pubitemid 40364825)
3. McEwen BS. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological reviews. Jul 2007; 87(3): 873-904. (Pubitemid 47086281)
4. Moreno-Smith M, Lutgendorf SK, Sood AK. Impact of stress on cancer metastasis. Future oncology. Dec 2010; 6(12): 1863-1881.
5. Zivkovic I, Rakin A, Petrovic-Djergovic D, Miljkovic B, Micic M. The effects of chronic stress on thymus innervation in the adult rat. Acta histochemica. 2005; 106(6): 449-458. (Pubitemid 40227418)
6. Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: Biobehavioral signaling pathways and interventions. J Clin Oncol Sep 10 2010; 28(26): 4094-4099.
7. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA: A cancer journal for clinicians. Nov-Dec 2011; 61(6): 409-418.
8. Tamim H, Boivin JF, Hanley J, Stang M, Collet JP. Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants. Pharmacoepidemiol Drug Saf. Oct 2006; 15(10): 689-697. (Pubitemid 44649507)
9. Vazquez SM, Mladovan AG, Perez C, Bruzzone A, Baldi A, Luthy IA. Human breast cell lines exhibit functional alpha2- adrenoceptors. Cancer Chemother Pharmacol Jul 2006; 58(1): 50-61.
10. Civantos Calzada B, Aleixandre de Artinano A. Alphaadrenoceptor subtypes. Pharmacol Res Sep 2001; 44(3): 195- 208.
11. Leineweber K, Buscher R, Bruck H, Brodde OE. Betaadrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol Jan 2004; 369(1): 1-22.
12. Lameh J, Cone RI, Maeda S, et al. Structure and function of G protein coupled receptors. Pharmaceutical research Dec 1990; 7(12): 1213-1221.
13. Docherty JR. Subtypes of functional alpha1- and alpha2- adrenoceptors. European journal of pharmacology Nov 13 1998; 361(1): 1-15. (Pubitemid 28522153)
14. Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Cancer Res May 1 2009; 69(9): 3727-3730.
15. Metaye T, Gibelin H, Perdrisot R, Kraimps JL. Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal Aug 2005; 17(8): 917-928. (Pubitemid 40719113)
16. Seshadri R, Shah PN. Modulation of steroid receptors in rat mammary glands. Indian journal of experimental biology Oct 1984; 22(10): 523-526. (Pubitemid 15224257)
17. Bruckmaier RM, Wellnitz O, Blum JW. Inhibition of milk ejection in cows by oxytocin receptor blockade, alphaadrenergic receptor stimulation and in unfamiliar surroundings. The Journal of dairy research Aug 1997; 64(3): 315- 325. (Pubitemid 127510067)
18. Piascik MT, Perez DM. Alpha1-adrenergic receptors: New insights and directions. J Pharmacol Exp Ther Aug 2001; 298(2): 403-410. (Pubitemid 32673390)
19. Hein L, Altman JD, Kobilka BK. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature Nov 11 1999; 402(6758): 181-184.
20. Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res Mar 1 2012; 18(5): 1201- 1206.
21. Luthy IA, Bruzzone A, Pinero CP, et al. Adrenoceptors: non conventional target for breast cancer? Current medicinal chemistry 2009; 16(15): 1850-1862.
22. Tatsuta M, Iishi H, Baba M, Nakaizumi A, Ichii M, Taniguchi H. Promotion by bombesin of gastric carcinogenesis induced by N-methyl-N'-nitro-N- nitrosoguanidine in Wistar rats. Cancer Res Oct 1 1989; 49(19): 5254-5257. (Pubitemid 19240456)
23. Fitzgerald PJ. Is norepinephrine an etiological factor in some types of cancer? Int J Cancer Jan 15 2009; 124(2): 257-263.
24. Iishi H, Tatsuta M, Baba M, Yamamoto R, Taniguchi H. Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in Wistar rats. Int J Cancer Mar 12 1992; 50(5): 834-839.
25. TatsutaM, Iishi H, Baba M, Taniguchi H. Enhanced induction of colon carcinogenesis by azoxymethane in Wistar rats fed a low-protein diet. Int J Cancer Jan 2 1992; 50(1): 108-111.
26. Tatsuta M, Iishi H, Baba M, Taniguchi H. Inhibition of azoxymethane-induced experimental colon carcinogenesis in Wistar rats by 6-hydroxydopamine. Int J Cancer Jan 21 1992; 50(2): 298-301.
27. Brandes LJ, Arron RJ, Bogdanovic RP, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res Jul 1 1992; 52(13): 3796- 3800.
28. Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF. The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer Jan 7 2002; 86(1): 92-97. (Pubitemid 34146347)
29. Dalton SO, Johansen C, Mellemkjaer L, et al. Antidepressant medications and risk for cancer. Epidemiology Mar 2000; 11(2): 171-176. (Pubitemid 30112018)
30. Tamim HM, Mahmud S, Hanley JA, Boivin JF, Stang MR, Collet JP. Antidepressants and risk of prostate cancer: A nested case-control study. Prostate Cancer Prostatic Dis 2008; 11(1): 53-60. (Pubitemid 351250330)
31. Toh S, Rodriguez LA, Hernandez-Diaz S. Use of antidepressants and risk of lung cancer. Cancer Causes Control Dec 2007; 18(10): 1055-1064. (Pubitemid 47498156)
32. Giessler C, Wangemann T, Silber RE, Dhein S, Brodde OE. Noradrenaline-induced contraction of human saphenous vein and human internal mammary artery: involvement of different alpha-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol Aug 2002; 366(2): 104-109. (Pubitemid 34762268)
33. Su F, Ouyang N, Zhu P, et al. Psychological stress induces chemoresistance in breast cancer by upregulating mdr1. Biochem Biophys Res Commun Apr 15 2005; 329(3): 888- 897. (Pubitemid 40347252)
34. Flint MS, Kim G, Hood BL, Bateman NW, Stewart NA, Conrads TP. Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1- dependent pathway. Psychoneuroendocrinology Nov 2009; 34(10): 1533-1541.
35. Re G, Badino P, Girardi C, Di Carlo F. Effects of a beta 2- agonist (clenbuterol) on cultured human (CG-5) breast cancer cells. Pharmacol Res Dec 1992; 26(4): 377-384. (Pubitemid 23036561)
36. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol Jul 1 2011; 29(19): 2645-2652.
37. Cakir Y, Plummer HK, 3rd, Tithof PK, Schuller HM. Betaadrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int J Oncol Jul 2002; 21(1): 153-157.
38. Strell C, Niggemann B, Voss MJ, Powe DG, Zanker KS, Entschladen F. Norepinephrine promotes the beta1-integrinmediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROalpha release. Mol Cancer Res Feb 2012; 10(2): 197-207.
39. Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat Mar 2000; 60(2): 153-166. (Pubitemid 30307475)
40. Shi M, Liu D, Duan H, et al. The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res Treat Jan 2011; 125(2): 351- 362.
41. Madden KS, Szpunar MJ, Brown EB. beta-Adrenergic receptors (beta-AR) regulate VEGF and IL-6 production by divergent pathways in high beta-AR-expressing breast cancer cell lines. Breast Cancer Res Treat Dec 2011; 130(3): 747-758.
42. Nilsson MB, Armaiz-Pena G, Takahashi R, et al. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem Oct 12 2007; 282(41): 29919-29926. (Pubitemid 350035290)
43. Lutgendorf SK, Cole S, Costanzo E, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res Oct 1 2003; 9(12): 4514-4521. (Pubitemid 37248410)
44. Hermes GL, Delgado B, Tretiakova M, et al. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A Dec 29 2009; 106(52): 22393-22398.
45. Williams JB, Pang D, Delgado B, et al. A model of geneenvironment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer Prev Res (Phila) Oct 2009; 2(10): 850-861.
46. Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res Sep 15 2010; 70(18): 7042-7052.
47. Madden KS, Szpunar MJ, Brown EB. Early impact of social isolation and breast tumor progression in mice. Brain Behav Immun May 17 2012.
48. Obeid E, Nanda R, Fu YX, Olopade OI. The role of tumor-associated macrophages in breast cancer progression (Review). Int J Oncol Jul 2013; 43(1): 5-12.
49. Dalton SO, Poulsen AH, Norgaard M, McLaughlin JK, Johansen C, Friis S. Tricyclic antidepressants and non-Hodgkin lymphoma. Epidemiology Jul 2008; 19(4): 546-549.
50. Fryzek JP, Poulsen AH, Lipworth L, et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat Jun 2006; 97(3): 231-236. (Pubitemid 43945753)
51. Shah SM, Carey IM, Owen CG, Harris T, Dewilde S, Cook DG. Does beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol Jul 2011; 72(1): 157-161.
52. Powe DG, Voss MJ, Zanker KS, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget Nov 2010; 1(7): 628-638.
53. Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: A populationbased study. J Clin Oncol Jul 1 2011; 29(19): 2635-2644.
54. Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat Sep 2011; 129(2): 549-556.
55. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer cell Mar 20 2012; 21(3): 309-322.
56. Pan D, Kocherginsky M, Conzen SD. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res Oct 15 2011; 71(20): 6360-6370.
57. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest Jul 1995; 96(1): 99-106.
58. Droms KA. Beta-adrenergic signalling in neoplastic lung type 2 cells: glucocorticoid-dependent and -independent defects. Br J Cancer Aug 1996; 74(3):432-438. (Pubitemid 26254574)
59. Vazquez SM, Pignataro O, Luthy IA. Alpha2-adrenergic effect on human breast cancer MCF-7 cells. Breast Cancer Res Treat May 1999; 55(1): 41-49. (Pubitemid 29353973)
60. Bruzzone A, Pinero CP, Castillo LF, et al. Alpha2- adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol Oct 2008; 155(4): 494- 504.
61. Re G, Badino P, Odore R, Galaverna D, Girardi C. Characterization of alpha-adrenoceptor subtypes in smooth muscle of equine ileum. Am J Vet Res Sep 2001; 62(9): 1370-1374. (Pubitemid 33607070)